List of Asterias Biotherapeutics patents

List of Asterias Biotherapeutics patents

List of University of Sheffield patents

List of Gibson Guitar Corporation patents

List of ALZHEON, INC. patents

Investment funds in Birmingham, Alabama

Investors in Dapper Labs

Patents where

Current Assignee

Name

is

Asterias Biotherapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8637311 Human embryonic stem cells genetically modified to contain a nucleic acid and cultured with fibroblast growth factor	Patent 8637311 was granted and assigned to Asterias Biotherapeutics on January, 2014 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	8637311	January 28, 2014
	‌ US Patent 9790466 Neural cell populations from primate pluripotent stem cells	Patent 9790466 was granted and assigned to Asterias Biotherapeutics on October, 2017 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	9790466	October 17, 2017
	‌ US Patent 9803174 Neural progenitor cell populations	Patent 9803174 was granted and assigned to Asterias Biotherapeutics on October, 2017 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	9803174	October 31, 2017
	‌ US Patent 9238794 Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells	Patent 9238794 was granted and assigned to Asterias Biotherapeutics on January, 2016 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	9238794	January 19, 2016
	‌ US Patent 10286009 Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury	Patent 10286009 was granted and assigned to Asterias Biotherapeutics on May, 2019 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	10286009	May 14, 2019
	‌ US Patent 9074182 Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes	Patent 9074182 was granted and assigned to Asterias Biotherapeutics on July, 2015 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	9074182	July 7, 2015
	‌ US Patent 9243229 Synthetic surfaces for culturing stem cell derived cardiomyocytes	Patent 9243229 was granted and assigned to Asterias Biotherapeutics on January, 2016 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	9243229	January 26, 2016
	‌ US Patent 9074181 Suspension culture of human embryonic stem cells	Patent 9074181 was granted and assigned to Asterias Biotherapeutics on July, 2015 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	9074181	July 7, 2015
	‌ US Patent 9062289 Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells	Patent 9062289 was granted and assigned to Asterias Biotherapeutics on June, 2015 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	9062289	June 23, 2015
	‌ US Patent 10059939 Screening methods for human embryonic stem cells	Patent 10059939 was granted and assigned to Asterias Biotherapeutics on August, 2018 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	10059939	August 28, 2018
	‌ US Patent 10351821 Neural cell populations from primate pluripotent stem cells	Patent 10351821 was granted and assigned to Asterias Biotherapeutics on July, 2019 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	10351821	July 16, 2019
	‌ US Patent 9587223 Protocols for making hepatocytes from embryonic stem cells	Patent 9587223 was granted and assigned to Asterias Biotherapeutics on March, 2017 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	9587223	March 7, 2017
	‌ US Patent 8951800 Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation	Patent 8951800 was granted and assigned to Asterias Biotherapeutics on February, 2015 by the United States Patent and Trademark Office.		Asterias Biotherapeutics		United States Patent and Trademark Office	8951800	February 10, 2015
	‌ US Patent 10344262 Differentiation of primate pluripotent stem cells to hematopoietic lineage cells	Patent 10344262 was granted and assigned to Asterias Biotherapeutics on July, 2019 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	10344262	July 9, 2019
	‌ US Patent 9745550 Synthetic surfaces for culturing stem cell derived cardiomyocytes	Patent 9745550 was granted and assigned to Asterias Biotherapeutics on August, 2017 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	9745550	August 29, 2017
	‌ US Patent 11123374 Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injury	Patent 11123374 was granted and assigned to Asterias Biotherapeutics on September, 2021 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	11123374	September 21, 2021
	‌ US Patent 10221390 Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells	Patent 10221390 was granted and assigned to Asterias Biotherapeutics on March, 2019 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	10221390	March 5, 2019
	‌ US Patent 11920155 Oligodendrocyte progenitor cell compositions	Patent 11920155 was granted and assigned to Asterias Biotherapeutics on March, 2024 by the United States Patent and Trademark Office.	Asterias Biotherapeutics	Asterias Biotherapeutics		United States Patent and Trademark Office	11920155	March 5, 2024

18 results

0 selected

18 results

0 selected